BACKGROUND: Rotaviral gastroenteritis (RVGE) is the leading cause of severe diarrhea in children under five years of age worldwide. This comprehensive review aims to estimate the burden of RVGE among children in Central and Eastern Europe. METHODS: An extensive search of the biomedical literature (1999-2009) was conducted in major databases. Studies pertaining to the epidemiology and burden of rotavirus in Central and Eastern Europe were captured and data from each country was systematically extracted and compared. RESULTS: This literature search captured 38 studies pertaining to RVGE infection in the region. Among children under 15 years of age, RVGE accounted for between 22.0% and 55.3% of all cases of acute gastroenteritis per year. For most countries RVGE was most common in the winter months, although it was reported year round in Bulgaria. Geographical comparison of genotyping data revealed that three genotype combinations, G1P[8], G4P[8], and G2P[4] were present in all countries for which full genotyping data was available. Genotype predominance varied on a season to season basis within each country. Only limited data was available for healthcare resource utilization, and economic burden for this region. CONCLUSIONS: RVGE is a common disease associated with significant morbidity, and mortality. While three genotype combinations currently predominate in the region, the dominance of a certain serotype can change dramatically from year to year and from country to country. A vaccination program with broad serotype coverage may help to decrease the burden of RVGE in Central and Eastern Europe.
BACKGROUND: Rotaviral gastroenteritis (RVGE) is the leading cause of severe diarrhea in children under five years of age worldwide. This comprehensive review aims to estimate the burden of RVGE among children in Central and Eastern Europe. METHODS: An extensive search of the biomedical literature (1999-2009) was conducted in major databases. Studies pertaining to the epidemiology and burden of rotavirus in Central and Eastern Europe were captured and data from each country was systematically extracted and compared. RESULTS: This literature search captured 38 studies pertaining to RVGE infection in the region. Among children under 15 years of age, RVGE accounted for between 22.0% and 55.3% of all cases of acute gastroenteritis per year. For most countries RVGE was most common in the winter months, although it was reported year round in Bulgaria. Geographical comparison of genotyping data revealed that three genotype combinations, G1P[8], G4P[8], and G2P[4] were present in all countries for which full genotyping data was available. Genotype predominance varied on a season to season basis within each country. Only limited data was available for healthcare resource utilization, and economic burden for this region. CONCLUSIONS: RVGE is a common disease associated with significant morbidity, and mortality. While three genotype combinations currently predominate in the region, the dominance of a certain serotype can change dramatically from year to year and from country to country. A vaccination program with broad serotype coverage may help to decrease the burden of RVGE in Central and Eastern Europe.
Authors: K Bányai; B Jiang; A Bogdán; B Horváth; F Jakab; E Meleg; V Martella; L Magyari; B Melegh; G Szucs Journal: J Clin Virol Date: 2006-09-25 Impact factor: 3.168
Authors: Carlo Giaquinto; Pierre Van Damme; Frederic Huet; Leif Gothefors; Melanie Maxwell; Peter Todd; Liviana da Dalt Journal: J Infect Dis Date: 2007-05-01 Impact factor: 5.226
Authors: Carlo Giaquinto; Pierre Van Damme; Frédéric Huet; Leif Gothefors; Marie Van der Wielen Journal: J Infect Dis Date: 2007-05-01 Impact factor: 5.226
Authors: Krisztián Bányai; Agnes Bogdán; Péter Kisfali; Péter Molnár; Ilona Mihály; Béla Melegh; Vito Martella; Jon R Gentsch; György Szücs Journal: Emerg Infect Dis Date: 2007-06 Impact factor: 6.883
Authors: Mohammad Howidi; Nawal Al Kaabi; Antoine C El Khoury; Agnes Brandtmüller; Laszlo Nagy; Etienne Richer; Wissam Haddadin; Mohamad S Miqdady Journal: BMC Pediatr Date: 2012-06-18 Impact factor: 2.125
Authors: Farah Aladin; Alexandra W C Einerhand; Janneke Bouma; Sandra Bezemer; Pim Hermans; Danielle Wolvers; Kate Bellamy; Leon G J Frenken; Jim Gray; Miren Iturriza-Gómara Journal: PLoS One Date: 2012-03-05 Impact factor: 3.240
Authors: Galina V Semeiko; Marina A Yermalovich; Nadezhda Poliakova; Slavica Mijatovic-Rustempasic; Tara K Kerin; Annemarie Wasley; Dovile Videbaek; Jon R Gentsch; Michael D Bowen; Elena O Samoilovich Journal: Infect Genet Evol Date: 2014-09-16 Impact factor: 3.342